skip to content
Systematic Reviews of Treatments for Lung Diseases
Follow the links below to find summaries of systematic reviews of evidence for the effectiveness of treatments for lung diseases.
Reviewed January 2012
42 Resources Found
| Title: | Nebulised morphine for severe interstitial lung disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Nebulized morphine has been reported to have some beneficial effect on breathlessness and exercise limitation in terminally ill patients with chronic lung disease. Patients with end-stage interstitial lung disease might also benefit from treatment of br... |
| Date: | May 2011 |
| Title: | Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | When people in intensive care need assistance breathing, they may need to have a breathing tube inserted down through their windpipe (trachea or airway - the passage to the lungs). After it is taken out (extubation), the airways can be swollen (inflamed... |
| Date: | Jan 2011 |
| Title: | Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | There is no strong evidence of benefit from routine use of loop diuretics in preterm babies at risk of, or with, chronic lung disease. Lung disease in babies born early (preterm) is often complicated with excess of water. Medications that reduce body wa... |
| Date: | Jan 2011 |
| Title: | Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | There is no strong evidence of benefit from routine use of distal diuretics in preterm infants with chronic lung disease. Lung disease in infants born early (preterm) is often complicated with excess of water. Medications that reduce body water (diureti... |
| Date: | Dec 2010 |
| Title: | Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | There is not enough evidence to show the long term effect of using Alpha-1 proteinase inhibitor for chronic lung disease in premature babies. Inflammation of the lungs is one of the causes of chronic lung disease (CLD) in babies born before 37 weeks. Ba... |
| Date: | Oct 2010 |
| Title: | Domiciliary oxygen for interstitial lung disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Oxygen therapy is used to treat patients with interstitial lung disease (ILD) with low arterial blood oxygen levels. This review evaluated the effect of domiciliary long-term oxygen therapy on survival and quality of life in patients with ILD. Only one ... |
| Date: | Oct 2010 |
| Title: | Non-steroid agents for idiopathic pulmonary fibrosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Idiopathic pulmonary fibrosis is a form of progressive lung disease which ultimately leads to death. The cause is unknown, but the disease is characterised by scar tissue in the lungs. This prevents the lungs from working effectively. Standard treatment... |
| Date: | Jul 2010 |
| Title: | Volume-targeted versus pressure-limited ventilation in the neonate |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Preterm babies may need help to breathe. The risk of lung problems increases with increasing immaturity. For some babies, the assistance of a ventilator (breathing machine) can be life saving, however ventilators may also injure the baby's immature lu... |
| Title: | Embolisation therapy for pulmonary arteriovenous malformations |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | A pulmonary arteriovenous malformation is an abnormal connection between arteries and veins in the lung. It is known to cause serious complications such as stroke, brain abscess, bleeding in the lungs and exercise intolerance. Embolisation therapy is th... |
| Date: | Apr 2010 |
| Title: | Physical training for interstitial lung disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | People with ILD often have reduced exercise capacity and shortness of breath during exercise. Physical training can improve well being in people with other chronic lung diseases, but little is known regarding physical training in ILD. We conducted a rev... |
| Date: | Feb 2010 |
| Title: | Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Alpha-1 antitrypsin deficiency is an inherited disorder that can cause lung disease. It affects about 1 in 1600 to 5000 people. Those with lung disease suffer from shortness of breath, reduced ability to exercise and wheezing. People who smoke are more ... |
| Date: | Jan 2010 |
| Title: | Antibiotics for treating acute chest syndrome in people with sickle cell disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Sickle cell disease affects millions of people throughout the world. Acute chest syndrome is a major cause of illness and death in people with sickle cell disease. Symptoms include fever, chest pain and a raised white blood cell count. Acute infection o... |
| Date: | Nov 2009 |
| Title: | Vena caval filters for the prevention of pulmonary embolism |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Blood clots in the lungs are called pulmonary emboli. They originate in the legs, fragment and travel to the lungs via the inferior vena cava. Vena caval filters are metal alloy devices inserted within the inferior vena cava to trap blood clots and thus... |
| Date: | Oct 2009 |
| Title: | Interventions at caesarean section for reducing the risk of aspiration pneumonitis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Stomach contents can regurgitate up the gullet into the wind pipe and enter the lungs when there is no cough reflex, e.g. during general anaesthesia. Solid food can block airways and cause breathing difficulties. The acidic liquid from the stomach can d... |
| Date: | Oct 2009 |
| Title: | Aerosolized diuretics for preterm infants with (or developing) chronic lung disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | There is no evidence of benefit from routine use of inhaled diuretics in preterm babies at risk of chronic lung disease. Lung disease in babies born early (preterm) is often complicated with excess accumulation of water in the lungs. Medications that re... |
| Date: | Sep 2009 |
| Title: | Cromolyn sodium for the prevention of chronic lung disease in preterm infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Cromolyn sodium administered in the first few days of life has not been shown to prevent chronic lung disease in preterm infants. Preterm babies (babies born before 37 weeks gestation) often need to be given oxygen for lung problems for many weeks becau... |
| Date: | Aug 2009 |
| Title: | Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Not enough evidence to show the effect of bronchodilators for chronic lung disease in preterm babies. Chronic lung disease (CLD) is common in babies who are born before 34 weeks gestation. Bronchodilators are drugs that cause widening of the air passag... |
| Date: | Jul 2009 |
| Title: | Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Thrombosis of the deep veins and subsequent embolism to the lungs are both prevalent and dangerous. They usually require either subcutaneous or intravenous injections of medications which aim to stop this hyper-coagulant state, followed by oral medicati... |
| Date: | Jul 2009 |
| Title: | Thrombolytic therapy for pulmonary embolism |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | A blood clot that lodges in the main artery of the lungs (pulmonary embolism) strains the right side of the heart, affects blood circulation and can be fatal. Patients are also at risk of new blood clots forming (recurrence). With large blood clots (mas... |
| Date: | Apr 2009 |
| Title: | High frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmonary dysfunction born at or near term |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | In babies born at or near term (over 34 weeks gestation) who have severe respiratory failure due to lung disease, there is no evidence from randomized controlled trials to suggest that the use of high frequency oscillatory ventilation is better than con... |
